Andre Marziali, PhD 

Founder, Chief Scientific Officer

A leading innovator, educator, and entrepreneur with over 20 years’ experience in developing tools for life science research and technologies for nucleic acid analysis, Andre founded Boreal Genomics with colleagues from the University of British Columbia in 2007.

Andre received his B.A.Sc. in Engineering Physics from UBC in 1989, and his Ph.D. in Physics from Stanford University in 1994. He subsequently worked for several years with Prof. Ron Davis, in the Stanford DNA Sequencing Technology Center, developing instruments for DNA sequencing and sample purification. He returned to Canada in 1998, as an Assistant Professor at University of British Columbia in the Department of Physics and Astronomy, where he founded the Applied Biophysics Laboratory and the Genome BC Technology Development Platform. In 2005 he was appointed Director of the Engineering Physics program at UBC.

In 2004, Andre co-invented the concept of using synchronous mobility perturbations to create divergent velocity fields for selective focusing of nucleic acids, the technology which forms the basis for Boreal’s platforms. He has been awarded the 2004 BC Innovation Council Young Innovator award, the 2007 Association for Lab Automation Innovation Award, and the 2011 Life Science BC Award for Innovation and Achievement.



David Broemeling 

VP Marketing & Business Development

As a co-founder of Boreal Genomics, David has played an integral role in all stages of the company’s growth from the early days of technology innovation and product development.

David received his B.A.Sc. in Engineering Physics from the University of British Columbia in 2004, and subsequently worked in Dr. Marziali’s Applied Biophysics Lab as lab manager and scientific engineer. Upon founding of Boreal Genomics, David served as Director of Operations prior to taking over leadership of marketing and commercial growth of the business.

For Business Development and other commercial inquiries, David can be contacted at



Matthew Wiggin, PhD

Head of Product Development

Matthew joined Boreal in June 2011 to lead research and development focused on bringing Boreal’s technologies into clinical markets. He oversees assay development, productization, and Boreal’s service laboratory supporting translational research from academic collaborators and pharma partners.

Matthew holds joint undergraduate degrees in Molecular Biology and Electromechanical Engineering, and Ph.D. in Molecular Biology from the University of British Columbia. He has a strong background in detection technology development from his graduate studies and Post Doctoral work at Delft University in the Netherlands.



Joel Pel, PhD

Head of Technology Development

A co-founder of Boreal Genomics, Joel leads a team focused on the innovation and development of the company’s core technologies. Joel has been closely involved in both instrument and assay product development, and is a co-inventor on many of Boreal’s patents.

Joel received his B.A.Sc. in Engineering Physics from UBC in 2005, and his Ph.D. in Physics from UBC in 2009. Joel studied under Dr. Marziali, where his thesis work was the demonstration and initial development of what is now Boreal’s SCODA technology.